Complete cardiovascular assessment
Who should have a cardiovascular assessment?
Although everyone can benefit from a basic cardiovascular assessment, certain profiles warrant more comprehensive and regular investigation:
- Man aged 40 or over, or woman aged 50 or over (or menopausal), with no known symptoms
- Family history of early heart disease: myocardial infarction or cardiovascular death before age 55 in a male first-degree relative, before age 65 in a female relative.
- Presence of one or more risk factors: high blood pressure, diabetes, dyslipidemia, active or past smoking, abdominal obesity
- Marked sedentary lifestyle, wishing to resume intense physical activity after a long period of inactivity
- Elite athletes or individuals who practice endurance sports intensively
- Individuals with conditions associated with increased cardiovascular risk: chronic kidney disease, sleep apnea, rheumatoid arthritis, lupus, severe psoriasis
- Personal history of cardiovascular event: heart attack, stroke, angina, heart surgery
- Individuals with suggestive symptoms: chest pain upon exertion, unexplained shortness of breath, palpitations, fainting or near-fainting spells
Components of a complete cardiovascular assessment
The cardiovascular assessment is broken down into several levels of investigation, from the simplest to the most specialized, depending on the patient's clinical profile:
| Component | What does it consist of | What it detects |
|---|---|---|
| Patient history and physical examination | Comprehensive medical examination: personal and family history, lifestyle habits, symptoms, medications; cardiac and pulmonary auscultation, palpation of peripheral pulses | Heart murmurs, arrhythmias detectable by auscultation, signs of heart failure, peripheral artery disease |
| Blood pressure measurement | Taken from both arms in sitting and standing positions; sometimes 24-hour ambulatory blood pressure monitoring (ABPM) | Arterial hypertension, orthostatic hypotension, blood pressure asymmetry suggesting dissection or stenosis |
| Complete lipid profile | Fasting blood test: total cholesterol, LDL, HDL, triglycerides, TC/HDL ratio, non-HDL cholesterol | Dyslipidemia, familial hypercholesterolemia, hypertriglyceridemia |
| Fasting blood glucose and HbA1c | Blood tests evaluating glucose metabolism | Type 2 diabetes, prediabetes, insulin resistance |
| Resting electrocardiogram (ECG) | Recording of the heart's electrical activity via electrodes placed on the skin; lasts a few minutes | Arrhythmias, conduction disturbances, signs of past ischemia or infarction, ventricular hypertrophy |
| Body mass index and waist circumference | Standardized anthropometric measurements | Overweight, abdominal obesity, metabolic syndrome |
| Kidney function test | Creatinine, eGFR, urinary microalbumin | Kidney damage secondary to hypertension or diabetes; independent cardiovascular risk factor |
| Thyroid panel (TSH) | TSH (Thyroid-Stimulating Hormone) Dosage | Hypothyroidism or hyperthyroidism can contribute to dyslipidemia, arrhythmia, or hypertension |
| High-sensitivity C-reactive protein (hs-CRP) | Blood marker of low-grade systemic inflammation | Residual cardiovascular risk, chronic inflammation associated with atherosclerosis |
| Uric acid | Blood count | Hyperuricemia associated with increased cardiovascular risk, insulin resistance, gout |
Specialized cardiovascular examinations
According to the results of the baseline assessment and the risk profile, further complementary investigations can be prescribed or recommended:
| Review | Description | Main indications |
|---|---|---|
| Transthoracic echocardiogram | Echocardiogram using ultrasound to visualize heart structure and function in real-time | Suspected heart failure, heart murmur, severe hypertension, unexplained shortness of breath, history of myocardial infarction |
| Stress test | ECG performed during treadmill or stationary bike exercise, with continuous monitoring of heart rate and blood pressure | Stress myocardial ischemia screening, functional capacity assessment, exertional chest pain |
| Holter ECG (ambulatory recording) | Continuous ECG recording for 24 to 48 hours (or longer) via a small portable device | Palpitations, syncope, suspected paroxysmal atrial fibrillation, evaluation of antiarrhythmic treatment efficacy |
| Ambulatory Blood Pressure Monitoring (ABPM) | Automatic blood pressure recording every 15 to 30 minutes for 24 hours under normal living conditions | White coat hypertension, masked hypertension, assessment of circadian blood pressure profile, treatment resistance |
| Coronary Artery Calcium Score | Thoracic scanner without injection measuring the quantification of calcium deposits in the coronary arteries | Refined cardiovascular risk assessment in intermediate-risk patients, therapeutic decision-making aid (statins) |
| Doppler ultrasonography of the supra-aortic trunks | Carotid and vertebral artery ultrasound measuring intima-media thickness and screening for atheromatous plaques | Screening for early atherosclerosis, history of stroke or TIA, high cardiovascular risk |
| Ankle-brachial systolic index (ABSI) | Ankle-brachial pressure index, measured by Doppler | Screening for peripheral arterial disease, intermittent claudication |
| Coronary angiogram or coronary CT angiogram | Coronary artery imaging with or without contrast injection | Suspicion of significant coronary obstruction, cardiac preoperative assessment, refractory atypical chest pain |
Cardiovascular Risk Factors: Modifiable and Non-Modifiable
The cardiovascular assessment identifies and quantifies all risk factors, whether they are amenable to intervention or not.
| Category | Risk factors | Possible support |
|---|---|---|
| Unmodifiable | Age (male > 45 years, female > 55 years), male sex, family history of premature coronary artery disease, ethnicity | Enhanced surveillance, earlier screening, lower intervention thresholds |
| Major modifications | High blood pressure, dyslipidemia, diabetes, smoking, abdominal obesity, sedentary lifestyle | Medication, lifestyle changes, smoking cessation |
| Emerging Modifiables | Metabolic syndrome, sleep apnea, chronic inflammation (high hs-CRP), chronic psychosocial stress, pro-inflammatory diet | Apnea treatment, stress management, dietary optimization |
| Related to chronic illnesses | Chronic kidney disease, autoimmune diseases (lupus, RA), HIV on antiretroviral treatment, history of pre-eclampsia | Enhanced cardiovascular monitoring, treatment of the underlying disease |
Interpretation and follow-up of results
The results of the cardiovascular assessment are always interpreted as a whole, not in isolation. A single slightly abnormal parameter is not enough to define a person's actual risk. The doctor integrates all the data to develop a personalized plan:
- Global 10-year cardiovascular risk calculation: low, intermediate, or high, guiding intervention thresholds
- Identification of priority modifiable factors to address based on their individual impact on overall risk
- Establishing personalized therapeutic goals: LDL, blood pressure, and HbA1c targets based on profile
- Action plan including lifestyle modifications: Mediterranean-type diet, physical activity, smoking cessation, weight management
- Initiation or adjustment of preventive drug treatment if the calculated risk justifies it
- Follow-up Planning: Check-up Frequency Based on Risk Level and Parameter Stability
Cardiovascular Assessment Preparation
To obtain reliable results for biological analyses and functional examinations, a few simple guidelines should be followed:
- 9 to 12-hour fast before blood draw for lipid profile and blood sugar (still water allowed)
- Avoid intense physical activity within 24 hours before a stress ECG or blood draw.
- Inform the doctor of all medications, supplements, and natural products being consumed.
- Provide previous test results if available, to allow for comparison over time
- Report any recent symptoms, even if brief: chest pain, shortness of breath, palpitations, or fainting.
- Wear comfortable clothing that allows for electrode placement if an ECG is planned.
- Avoid caffeine and nicotine within 2 to 3 hours of taking your blood pressure.
Certain symptoms should never be ignored while waiting for a check-up appointment: crushing chest pain radiating to the left arm, jaw, or back; sudden onset of severe shortness of breath at rest; rapid and sustained palpitations with a feeling of malaise; loss of consciousness or sudden fainting; sudden weakness in a limb or facial drooping that could suggest a stroke.
In the presence of these signs, immediately call 911 or go to the nearest emergency room without delay. These conditions constitute cardiovascular emergencies where every minute counts to limit lasting damage.
Consult at Clinique Omicron
Clinique Omicron offers comprehensive and personalized cardiovascular assessments at several service points across Quebec. A physician or specialized nurse practitioner (SNP) can coordinate all evaluations, interpret your results within their overall context, and develop a prevention plan tailored to your risk profile with you. First-line examinations can be performed directly at the clinic, and specialized investigations will be referred to cardiology partners. In-person and telemedicine consultations are available. To book an appointment at one of our branches in Montreal, the South Shore, or elsewhere in Quebec, visit cliniqueomicron.ca.
The content of this page is provided for informational purposes only and is not intended to replace the advice of a qualified healthcare professional. Consult a physician for any symptoms, questions or decisions you may have regarding your health.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.